Phase 1 SCLC,Extensive Stage Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
SCLCSmall Cell Lung CancerSCLC,Extensive Stage+2 more
Peking University First Hospital30 enrolled1 locationNCT07508852
Recruiting
Phase 1Phase 2
Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
SCLC,Extensive StageSmall Cell Lung Cancer ( SCLC )Relapsed/Refractory SCLC
Beijing Biotech60 enrolled1 locationNCT07480213
Recruiting
Phase 1
A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment
SCLC,Extensive Stage
Peking University Cancer Hospital & Institute24 enrolled1 locationNCT07413042
Recruiting
Phase 1Phase 2
Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC
SCLC,Extensive Stage
Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.27 enrolled2 locationsNCT07136285
Recruiting
Phase 1
Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
SCLC,Extensive Stage
RayzeBio, Inc.49 enrolled15 locationsNCT05595460
Recruiting
Phase 1Phase 2
WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
Brain MetastasesSCLC,Extensive Stage
Fudan University56 enrolled1 locationNCT06243003